These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 35979433)
1. Metabolic syndrome and cardiovascular morbidity in patients with congenital adrenal hyperplasia. Barbot M; Mazzeo P; Lazzara M; Ceccato F; Scaroni C Front Endocrinol (Lausanne); 2022; 13():934675. PubMed ID: 35979433 [TBL] [Abstract][Full Text] [Related]
7. Long-term cardio-metabolic outcomes in patients with classical congenital adrenal hyperplasia: is the risk real? Gomes LG; Mendonca BB; Bachega TASS Curr Opin Endocrinol Diabetes Obes; 2020 Jun; 27(3):155-161. PubMed ID: 32304389 [TBL] [Abstract][Full Text] [Related]
8. Increased Cardiovascular and Metabolic Morbidity in Patients With 21-Hydroxylase Deficiency: A Swedish Population-Based National Cohort Study. Falhammar H; Frisén L; Hirschberg AL; Norrby C; Almqvist C; Nordenskjöld A; Nordenström A J Clin Endocrinol Metab; 2015 Sep; 100(9):3520-8. PubMed ID: 26126207 [TBL] [Abstract][Full Text] [Related]
9. Cognitive Function of Children and Adolescents With Congenital Adrenal Hyperplasia: Importance of Early Diagnosis. Messina V; Karlsson L; Hirvikoski T; Nordenström A; Lajic S J Clin Endocrinol Metab; 2020 Mar; 105(3):e683-91. PubMed ID: 31927590 [TBL] [Abstract][Full Text] [Related]
10. Effect of androgen excess and glucocorticoid exposure on metabolic risk profiles in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Paizoni L; Auer MK; Schmidt H; Hübner A; Bidlingmaier M; Reisch N J Steroid Biochem Mol Biol; 2020 Mar; 197():105540. PubMed ID: 31730799 [TBL] [Abstract][Full Text] [Related]
11. [Congenital adrenal hyperplasia due to 21-hydroxylase deficiency--management in adults]. Ambroziak U; Bednarczuk T; Ginalska-Malinowska M; Małunowicz EM; Grzechocińska B; Kamiński P; Bablok L; Przedlacki J; Bar-Andziak E Endokrynol Pol; 2010; 61 Suppl 1():7-21. PubMed ID: 22127631 [TBL] [Abstract][Full Text] [Related]
12. Cardiovascular health, growth and gonadal function in children and adolescents with congenital adrenal hyperplasia. Mooij CF; Webb EA; Claahsen van der Grinten HL; Krone N Arch Dis Child; 2017 Jun; 102(6):578-584. PubMed ID: 27974295 [TBL] [Abstract][Full Text] [Related]
13. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency - management in adults. Ambroziak U; Bednarczuk T; Ginalska-Malinowska M; Małunowicz EM; Grzechocińska B; Kamiński P; Bablok L; Przedlacki J; Bar-Andziak E Endokrynol Pol; 2010; 61(1):142-55. PubMed ID: 20205117 [TBL] [Abstract][Full Text] [Related]
14. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Völkl TM; Simm D; Beier C; Dörr HG Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852 [TBL] [Abstract][Full Text] [Related]
15. Recommendations for treatment of nonclassic congenital adrenal hyperplasia (NCCAH): an update. Trapp CM; Oberfield SE Steroids; 2012 Mar; 77(4):342-6. PubMed ID: 22186144 [TBL] [Abstract][Full Text] [Related]
19. Current and novel approaches to children and young people with congenital adrenal hyperplasia and adrenal insufficiency. Webb EA; Krone N Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):449-68. PubMed ID: 26051302 [TBL] [Abstract][Full Text] [Related]